Back to Search

DANIEL COURIEL, M.D.

M.D.

Hematology & Oncology Physician

NPI: 1275627309IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

4301095945(MI)9455685-1205(UT)42445(TN)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

4301095945(MI)
Internal Medicine Physician

Internal Medicine

Code: 207R00000X

4301095945(MI)
Hematology (Internal Medicine) Physician

Internal Medicine — Hematology

Code: 207RH0000X

4301095945(MI)

CMS Specialties

PrimaryHEMATOLOGY/ONCOLOGY

Education

OTHER

Class of 1987

Research & Publications (20)

Tacrolimus in hematopoietic stem cell transplantation.
PMID 19545215·Expert Opin Drug Metab Toxicol·2009
6-review
Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.
PMID 19011667·Bone Marrow Transplant·2009
3-trial
Extracorporeal photopheresis: past, present, and future.
PMID 19665258·J Am Acad Dermatol·2009
6-review
High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
PMID 18272911·Ann Oncol·2008
8-other
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.
PMID 18411419·Blood·2008
3-trial
Ancillary and supportive care in chronic graft-versus-host disease.
PMID 18503994·Best Pract Res Clin Haematol·2008
6-review
Endoscopic biopsy diagnosis of acute gastrointestinal graft-versus-host disease: rectosigmoid biopsies are more sensitive than upper gastrointestinal biopsies.
PMID 18028511·Am J Gastroenterol·2008
8-other
Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
PMID 18209724·Bone Marrow Transplant·2008
3-trial
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
PMID 18223284·Haematologica·2008
3-trial
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
PMID 17989720·Leukemia·2008
3-trial
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
PMID 18489993·Biol Blood Marrow Transplant·2008
3-trial
Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation.
PMID 17934530·Bone Marrow Transplant·2008
8-other
Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation.
PMID 17611563·Leukemia·2007
4-observational
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia.
PMID 17652620·Blood·2007
8-other
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
PMID 17262062·Bone Marrow Transplant·2007
3-trial
Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.
PMID 17382251·Biol Blood Marrow Transplant·2007
3-trial
Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
PMID 17530009·Bone Marrow Transplant·2007
8-other
Bilateral marginal keratitis associated with engraftment syndrome after hematopoietic stem cell transplantation.
PMID 17592333·Cornea·2007
5-case
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
PMID 17603511·Bone Marrow Transplant·2007
3-trial
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
PMID 17697969·Biol Blood Marrow Transplant·2007
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2000 CIRCLE OF HOPE DR, OFFICE 2151
SALT LAKE CITY, UT 84112

Location

Practice Location

2000 CIRCLE OF HOPE DR, SALT LAKE CITY, UT
(801) 213-2082

Quick Facts

NPI
1275627309
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
6
Locations
1
Years in Practice
39
Publications
20

Are you this provider?

Claim Your Profile